Alex Dickinson

Alex Dickinson is an accomplished board member and executive with extensive experience in the biotechnology and technology sectors. Currently serving as a board member for Sphere Fluidics Limited, Ryght, Gencove, and ChromaCode, Inc., Dickinson's roles include chairing Ryght, which leverages generative AI to enhance clinical trial efficiency, and co-founding ChromaCode, an X-prize winning company noted for its contributions to COVID testing and cancer diagnostics. Previous board membership includes PRA Health Sciences, a major clinical research organization, and significant leadership positions at Illumina as Senior Vice President, where revenue tripled, and at Luxtera, which pioneered digital-optical technologies. Academic credentials include an MBA from Columbia Business School and a PhD and Bachelor's in Electrical Engineering from the University of Adelaide.